Physician profile
Anna Hower
NPI 1184322281
$608.60
in general payments reported to CMS, 2019-2025
17 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $331 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $87.52 | 2024-2025 | Keytruda, Welireg, Keytruda Qlex |
| Takeda Pharmaceuticals U.S.A., INC. | $51.62 | 2024-2025 | Fruzaqla, Ninlaro |
| Abbvie INC. | $50.10 | 2024 | |
| Incyte Corporation | $49.05 | 2025 | Zynyz, Monjuvi |
| Celgene Corporation | $43.92 | 2024-2025 | Reblozyl |
| Gilead Sciences, INC. | $42.39 | 2024-2025 | Trodelvy |
| Genmab U.S., INC. | $41.57 | 2024-2025 | Epkinly |
| Astrazeneca Pharmaceuticals Lp | $41.05 | 2024-2025 | Tagrisso |
| Eisai INC. | $31.03 | 2024 | |
| Alnylam Pharmaceuticals INC. | $26.53 | 2025 | Givlaari |
| Daiichi Sankyo INC. | $24.78 | 2025 | Injectafer |
| Jazz Pharmaceuticals INC. | $23.30 | 2024 | |
| Novartis Pharmaceuticals Corporation | $22.24 | 2025 | |
| Geron Corporation | $22.12 | 2025 | Rytelo |
| Lilly USA, LLC | $22.08 | 2024 | Verzenio, Jaypirca |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Taiho Oncology, INC. | $15.10 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Hower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.